Cargando…
Lung clearance index to detect the efficacy of Aztreonam lysine inhalation in patients with cystic fibrosis and near normal spirometry – A single-centre feasibility study
Comparing the efficacy of inhaled antibiotics can be difficult in small groups of patients with cystic fibrosis and mild lung disease. In a feasibility study we compared Aztreonam lysine for inhalation solution (AZLI; Cayston(®)) to standard inhaled antibiotic therapy in patients with cystic fibrosi...
Autores principales: | Ellemunter, Helmut, Steinkamp, Gratiana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6733506/ https://www.ncbi.nlm.nih.gov/pubmed/31498805 http://dx.doi.org/10.1371/journal.pone.0221673 |
Ejemplares similares
-
Aztreonam Lysine Inhalation Solution in Cystic Fibrosis
por: Elson, Elizabeth Claire, et al.
Publicado: (2019) -
Clinical perspective on aztreonam lysine for inhalation in patients with cystic fibrosis
por: Daddario, Martha K, et al.
Publicado: (2010) -
Early and sustained improvements of lung clearance index from two to sixteen weeks of elexacaftor/tezacaftor/ivacaftor therapy in patients with cystic fibrosis—a real world study
por: Appelt, Dorothea, et al.
Publicado: (2023) -
Malignancies in patients with cystic fibrosis: a case series
por: Appelt, Dorothea, et al.
Publicado: (2022) -
Role of Inhalational Aztreonam Lysine in Lower Airway Infections in Cystic Fibrosis: An Updated Literature Review
por: Zeb, Mehwish, et al.
Publicado: (2022)